Gervasio Antonio Lamas, MD
July 17th, 2014
Clinical Events vs. Quality of Life: An Insider’s View of TACT
Gervasio Antonio Lamas, MD
TACT investigator Gervasio Lamas provides perspective on two new TACT papers that appear to have contradictory results.
November 19th, 2013
An Insider’s Look at TACT
Gervasio Antonio Lamas, MD
TACT investigator Gervasio Lamas provides an inside look at how the TACT trial began, the controversial journey so far, and what he hopes it will accomplish.
April 9th, 2013
The TACT Investigators Respond to Questions
Gervasio Antonio Lamas, MD, Daniel Mark, Christine Goertz, DC, PhD, Robin Boineau, M.D., M.A., Kerry L. Lee, Ph.D. and Harlan M. Krumholz, MD, SM
The publication in JAMA of the NIH’s Trial to Assess Chelation Therapy (TACT) has reignited a heated debate about the trial. The TACT investigators have generously agreed to respond to questions posed by Harlan Krumholz.
January 20th, 2012
Subclinical Atrial Fibrillation and the Risk of Stroke: An Interview
Daniela J Lamas, MD and Gervasio Antonio Lamas, MD
A NEJM editorial fellow interviews a NEJM editorialist about subclinical AF and the risk of stroke.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?